The homozygous Lepr mutation disrupts the long-form leptin receptor, so leptin cannot effectively signal through its normal hypothalamic pathway. This weakens central regulation of energy balance and contributes to increased food intake and abnormal metabolic control. The model therefore connects a defined signaling defect with the emergence of obesity, insulin resistance, and worsening glucose dysregulation.
Their phenotype reflects interacting metabolic disturbances rather than weight gain alone. Impaired leptin signaling promotes hyperphagia and severe obesity, while insulin resistance reduces effective glucose regulation. Over time, these abnormalities are associated with progressive hyperglycemia, making Db/db mice useful for examining how disrupted energy-balance signaling relates to broader metabolic disease.
The defining biological disturbance in Db/db mice is leptin-receptor dysfunction, specifically loss of effective signaling through the long-form Lepr receptor. This distinguishes them from models in which obesity may arise through another genetic mechanism. Comparing such models helps investigators determine which findings reflect receptor-level leptin signaling defects and which represent more general consequences of genetic obesity.
The model supports investigation of glucose regulation, adipose tissue biology, and diabetic complications alongside obesity and insulin resistance. These connected outcomes allow researchers to examine metabolic disease as a progressive process rather than as an isolated change in body mass. The same system can also help relate altered energy-balance signaling to downstream tissue and disease responses.
Researchers use the reproducible phenotype to investigate whether candidate treatments influence metabolic abnormalities associated with the model. Studies can focus on glucose regulation, insulin resistance, adipose tissue biology, or disease progression, depending on the therapeutic question. Because the animals show defined leptin-receptor dysfunction and progressive hyperglycemia, treatment responses can be interpreted within a consistent metabolic context.
Findings may clarify how impaired leptin signaling contributes to metabolic disease and may identify effects of interventions on glucose control, adipose tissue, or diabetic complications. The model is especially relevant when researchers need a consistent system for connecting an energy-balance defect with disease progression. Results also help frame how leptin-receptor dysfunction relates to other obesity mechanisms.